Apollo Endosurgery, Inc.

AUSTIN, TX · Medtech · Acquired

Minimally invasive endoscopic weight loss devices and systems

Claim this profile

Follows are private to you and power your alerts

Updated · endura.com

Sector
Medtech
Headquarters
AUSTIN, TX
Latest Form D
$25M, Jul 2020
Total capital
$62.4M
Federal grants
None on recordNo awards found in SBIR/STTR, NIH, NSF or DoD records.
Private capital raised
$62.4M
4 Form D · last Jul 2020
75 months since last filing
Federal contracts
None on recordNo federal contract awards found.
Granted patents
32
8 pending · first 2017
Rank in peer group#41 of 1112

Capital timeline

201020122014201620182020FEDERAL ↑EQUITY ↓Cumulative $62.4M1st Form D$4.9M2nd Form D$12.5M3rd Form D$20M
201020122014201620182020FEDERAL ↑EQUITY ↓Cumulative $62.4M2nd Form D$12.5M3rd Form D$20M

Latest events

  • Private capital raisedForm D · SEC · 4th filing$25M
  • Private capital raisedForm D · SEC · 3rd filing$20M
  • Private capital raisedForm D · SEC · 2nd filing$12.5M
  • Private capital raisedForm D · SEC · 1st filing$4.9M

Node area is scaled to amount. Form D reports securities sold, which can differ from an announced round; filings are numbered in the order they were made.

Standing among 1112 peers

Line = median

Medtech · Device

  • Granted patents#41 · top 4%

Cumulative measures favor older companies. Rankings describe position today, not outcome. Below the median, ranks show as a band rather than a number.

Founders and team

From SEC Form D filings
  • Bret SchwartzhoffExecutive OfficerNamed in SEC Form D filings
  • Bruce RobertsonDirectorNamed in SEC Form D filings
  • Christopher J. GostoutExecutive OfficerNamed in SEC Form D filings
  • David C. PacittiDirectorNamed in SEC Form D filings
  • Dennis McWilliamsExecutive Officer, DirectorNamed in SEC Form D filings
  • Jack B NielsenDirectorNamed in SEC Form D filings
Show all 18 people
  • John BarrDirectorNamed in SEC Form D filings
  • John W CreecyDirectorNamed in SEC Form D filings
  • John C. MolesphiniExecutive OfficerNamed in SEC Form D filings
  • Julie C. ShimerDirectorNamed in SEC Form D filings
  • Matthew CrawfordDirectorNamed in SEC Form D filings
  • Michael S. DotyExecutive OfficerNamed in SEC Form D filings
  • Richard J MeeliaDirectorNamed in SEC Form D filings
  • Rick J AndersonDirectorNamed in SEC Form D filings
  • R. Kent S. McGaughy, Jr.DirectorNamed in SEC Form D filings
  • Stefanie CavanaughExecutive OfficerNamed in SEC Form D filings
  • Todd NewtonExecutive Officer, DirectorNamed in SEC Form D filings
  • William D. McClellanDirectorNamed in SEC Form D filings

What it has protected

USPTO · 32 granted of 40
Show all 40 patent records

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.

Sources

Federal grants from SBIR/STTR, NIH, NSF and DoD records. Federal contracts from USAspending.gov. Private capital from SEC Form D. Patents from USPTO. Publications from OpenAlex. Regulatory activity from the Federal Register. Press matched on company name.

How to read this page

Figures show associations in public records, not causes or predictions. Nothing here is investment advice. An em-dash means no record was found under this company's name, not that none exists.

Data freshness

SEC Form D filings through . SBIR and STTR awards through .